HGH Clinical Trial Results Explained
Below is an explanation of the Clinical Trial Results done on Dr. Orman's Hgh Plus® human growth hormone releaser. Please note the following:
Patient
Information
Patient
#1 - (42 year old) is now secreting
Somatomedin C levels of which he may have secreted when he was a man in
his early 20s.
Patient #2 - (50 year old) is now secreting Somatomedin C
levels of which she may have secreted when she was a young woman in her
early 20s.
Patient #3 - (43 year old) is now secreting Somatomedin C
levels of which she may have secreted when she was a young woman in her
late 20s.
Patient #4 - (48 year old) is now secreting Somatomedin C
levels of which she may have secreted when she was a young woman in her
early 20s.
Patient #5 - (35 year old) is now secreting Somatomedin C
levels of which he may have secreted when he was a young man in his early
20s.
Patient #6 - (58 year old) is now secreting Somatomedin C
levels of which she may have secreted when she was a young woman in her
late 20s.
Patient #7 - (30 year old) is now secreting Somatomedin C
levels of which she may have secreted when she was a young woman in her
early 20s.
Patient #8 - (77 year old) is now secreting Somatomedin C
levels of which he may have secreted when he was a man in his late
50s.
Patient #9 - (62
year old) is now secreting Somatomedin C levels of which she may have
secreted when she was a young woman in her early
20s.
Patient #10- (38 year old) is now secreting Somatomedin C
levels of which he may have secreted when she was a woman in her early
30s.
Below is a summary of the Somatomedin C levels
of patients before and after taking Dr.
Orman's HghPlus®.
| Patient # - Sex |
Chronological Age |
Initial GH Level |
After Hgh Plus® Level |
Increase | Time |
| 1-M | 42 years old | 142 | 239 | 68.4% | 24 days |
| 2-F | 50 years old | 91 | 132 | 45.05% | 3 mo |
| 3-F | 43 years old | 98 | 147 | 55% | 2 mo |
| 4-F | 48 years old | 80 | 177 | 121.3% | 4 mo |
| 5-M | 35 years old | 139 | 234 | 68.34% | 1.5mo |
| 6-F | 58 years old | 98 | 121 | 23.5% | 2.5mo |
| 7-F | 39 years old | 165 | 288 | 74.54% | 9 days |
| 8-M | 77 years old | 61 | 77 | 26.23% | 35 days |
| 9-F | 62 years old | 45 | 132 | 193.3% | 4 mo. |
| 10-M | 38 years old | 130 | 177 | 236.2% | 1 mo |
Overall......71.186% average increase in
60.8 days.
Not included in this clinical trial
is the following reference of a typical GH injectable regimen:
Case
Study: A 56 year old male was taking indictable human growth hormone
for 10 months. His Somatomedin C levels rose 32 points or 21%over this 10
month time frame. The total cost for injectable (prescription) was
in excess of $9000.
* These case studies are individual cases.
Results per individual may vary depending upon age, compliance, genetics
and other mitigating factors.
..................................................................
|
|